The most recent CHEST guidelines on pulmonary arterial hypertension treatment support the integration of palliative care, noting significant improvements in outcomes observed in other pulmonary diseases, including lung cancer.
The optimal treatment approach for pulmonary arterial hypertension in pediatric patients depends upon the severity and underlying etiology of the disease.
In a review of repurposing medications for pulmonary arterial hypertension treatment, dichloroacetate, metformin, and rosiglitazone/pioglitazone had the most preclinical data to support their use.
It is estimated that more than 166 million Americans use dietary supplements and many healthcare providers are unfamiliar with how and whether these substances are regulated by the FDA.
Are dietary supplements necessary?
Individuals with gout have been shown to carry a significantly greater risk for cardiovascular (CV) events and CV-related mortality compared with those without gout.
Racism is embedded in all US institutions, including medicine — so what steps are being taken to improve the well-being of the healthcare workforce?
Patients implanted with leadless pacemakers had fewer complications in both short- and midterm events compared with patients who received transvenous pacemakers.
Current research suggests patients with pulmonary arterial hypertension may benefit from iron and vitamin D supplementation.
To aid in the prevention of preeclampsia, American College of Obstetricians and Gynecologists and the US Preventive Services Task Force recommend low-dose aspirin prophylaxis in patients with 1 or more high-risk factors.
